Validation of Partin Tables and Development of a Preoperative Nomogram for Japanese Patients With Clinically Localized Prostate Cancer Using 2005 International Society of Urological Pathology Consensus on Gleason Grading: Data From the Clinicopathological Research Group for Localized Prostate Cancer

Journal of Urology

Volumn 180, Issue 3, 2008, Pages 904-910

  Naito, Seiji ^a   Kuroiwa, Kentaro ^a   Kinukawa, Naoko ^b   Goto, Ken ^a   Koga, Hirofumi ^a   Ogawa, Osamu ^c   Murai, Masaru ^d   Shiraishi, Taizo ^e  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY HOSPITAL   (Japan)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Japan; nomograms; prostate; prostatectomy; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER INVASION; CANCER LOCALIZATION; CANCER RESEARCH; CANCER STAGING; CONTROLLED STUDY; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JAPANESE; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; NOMOGRAM; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; ROC CURVE; SEMINAL VESICLE; VALIDATION STUDY;

AREA UNDER CURVE; HUMANS; JAPAN; LOGISTIC MODELS; MALE; NEOPLASM STAGING; NOMOGRAMS; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROSTATECTOMY; PROSTATIC NEOPLASMS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 48649103986     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.05.047     Document Type: Article

References (20)

1. Hull G.W., Rabbani F., Abbas F., Wheeler T.M., Kattan M.W., and Scardino P.T. Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol 167 (2002) 528
2. Partin A.W., Mangold L.A., Lamm D.M., Walsh P.C., Epstein J.I., and Pearson J.D. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology 58 (2001) 843
3. Partin A.W., Yoo J., Carter H.B., Peason J.D., Chan D.W., Epstein J.I., et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 150 (1993) 110
4. Partin A.W., Kattan M.W., Subong E.N.P., Walsh P.C., Wojno K.J., Oesterling J.E., et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 277 (1997) 1445
5. Oesterling J.E., Kumamoto Y., Tsukamoto T., Girman C.J., Guess H.A., Masumori N., et al. Serum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white men. Br J Urol 75 (1995) 347
6. Epstein J.I., Allsbrook Jr. W.C., Amin M.B., Egevad L.L., Bastacky S., Lopez-Beltran A., et al. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 29 (2005) 1228
7. Oesterling J.E., Brendler C.B., and Epstein J.I. Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate. J Urol 138 (1987) 92
8. Cheng I., Yu M.C., Koh W.P., Pike M.C., Kolonel L.N., Henderson B.E., et al. Comparison of prostate-specific antigen and hormone levels among men in Singapore and the United States. Cancer Epidemiol Biomarkers Prev 14 (2005) 1692
9. Penson D.F., Grossfeld G.D., Li Y.P., Henning J.M., Lubeck D.P., and Carroll P.R. How well does the Partin nomogram predict pathological stage after radical prostatectomy in a community based population?. Results of the cancer of the prostate strategic urological research endeavor. J Urol 167 (2002) 1653
10. Blute M.L., Bergstralh E.J., Partin A.W., Walsh P.C., Kattan M.W., Scardino P.T., et al. Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer. J Urol 164 (2000) 1591
11. Graefen M., Augustin H., Karakiewicz P.I., Hammerer P.G., Haese A., and Palisaar J. Can predictive models for prostate cancer patients derived in the United States of America be utilized in European patients?. A validation study of the Partin tables. Eur Urol 43 (2003) 6
12. Augustin H., Eggert T., Wenske S., Karakiewicz P.I., Palisaar J., Daghofer F., et al. Comparison of accuracy between the Partin tables of 1997 and 2001 to predict final pathological stage in clinically localized prostate cancer. J Urol 171 (2004) 177
13. Eskicorapci S.Y., Karabulut E., Turkeri L., Baltaci S., Cal C., Toktas G., et al. Validation of 2001 Partin tables in Turkey: a multicenter study. Eur Urol 47 (2005) 185
14. Graefen M., Karakiewicz P.I., Cagiannos I., Quinn D.I., Henshall S.M., Grygiel J.J., et al. International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy. J Clin Oncol 20 (2002) 3206
15. Touijer K., Kuroiwa K., Vickers A., Reuter V.E., Hricak H., Scardino P.T., et al. Impact of a multidisciplinary continuous quality improvement program on the positive surgical margin rate after laparoscopic radical prostatectomy. Eur Urol 49 (2006) 853
16. Egawa S., Suyama K., Arai Y., Matsumoto K., Tsukayama C., Kuwao S., et al. A study of pretreatment nomograms to predict pathological stage and biochemical recurrence after radical prostatectomy for clinically resectable prostate cancer in Japanese men. Jpn J Clin Oncol 31 (2001) 74
17. Srigley J.R., Amin M.B., Bostwick D.G., Grignon D.J., Hammond M.E.H., and Schramm J. Updated protocol for the examination of specimens from patients with carcinomas of the prostate gland: a basis for checklists. Cancer Committee. Arch Pathol Lab Med 124 (2000) 1034
18. Egevad L., Allsbrook Jr. W.C., and Epstein J.I. Current practice of Gleason grading among genitourinary pathologists. Hum Pathol 36 (2005) 5
19. Albertsen P.C., Hanley J.A., Barrows G.H., Penson D.F., Kowalczyk P.D.H., Sanders M.M., et al. Prostate cancer and the Will Rogers phenomenon. J Natl Cancer Inst 97 (2005) 1248
20. Feinstein A.R., Sosin D.M., and Wells C.K. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 312 (1985) 1604